한글목차

웨어러블 인젝터 동향 및 전망

웨어러블 인젝터 세계 시장의 미래는 병원 및 클리닉과 재택 의료 시장에서의 기회로 인해 유망한 것으로 보입니다. 웨어러블 인젝터 세계 시장은 2024년부터 2030년까지 9.5%의 CAGR로 2030년까지 약 146억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 환자의 편의성에 대한 관심 증가와 재택 치료에 대한 수요 증가입니다.

• Lucintel의 예측에 따르면, 유형별 카테고리에서 온 바디 인젝터는 집에서 쉽게 사용할 수 있고, 방수 기능이 있으며, 피부(위)에 편안하게 착용할 수 있어 인기가 높아지고 있으며, 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다.
• 최종 용도 카테고리 중 재택 의료는 약물 자가 투여에 대한 수요 증가와 의료비 절감 요구로 인해 예측 기간 동안 높은 성장이 예상됩니다.
• 지역별로는 북미가 만성질환 및 생활습관병 환자 수 증가, 탄탄한 헬스케어 인프라, 주요 기업의 존재 등으로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

웨어러블 인젝터 시장의 전략적 성장 기회

웨어러블 인젝터 시장의 확대는 새로운 기술의 부상과 만성질환의 증가와 관련이 있습니다. 웨어러블 인젝터는 유리한 전략적 시장 기회를 창출하고 있습니다. 이러한 개선은 환자의 경험을 향상시킬 뿐만 아니라 기업이나 혁신가에 관계없이 의료 산업에 기회를 창출하는 것을 목표로 합니다.

• 당뇨병 관리 : 당뇨병이 전염병 수준에 도달함에 따라 웨어러블 인젝터 제조의 수천 가지 개발은 당뇨병 관리에 초점을 맞추고 있습니다. 이러한 기기는 인슐린 투여, 혈당치의 지속적인 모니터링 및 혈당 측정기와의 상호 작용을 개선합니다. 이러한 기술 혁신은 환자의 순응도와 혈당 조절에 긍정적인 영향을 미칩니다. 또한, 환자 중심의 설계를 개발하고 의료진과의 원활한 소통을 통해 삶의 질을 향상시키고 새로운 기능을 기기에 통합할 수 있습니다.
• 암 치료 : 종양학 분야에서 웨어러블 인젝터를 사용하여 화학요법 및 표적 치료제를 투여하는 것에 대한 관심이 증가하고 있습니다. 이러한 장치는 제어되고 지속적인 약물 흐름을 가능하게 하며, 기존 투여 방법에 비해 부작용을 최소화하면서 약리학적 효능을 향상시킬 수 있습니다. 개별 암 환자를 위한 첨단 약물전달 시스템과 치료 모니터링 기능을 갖춘 웨어러블 인젝터를 개발할 수 있는 기회가 있습니다.
• 자가 면역 질환 : 류마티스 관절염, 다발성 경화증과 같은 자가 면역 질환과의 싸움에서 웨어러블 인젝터는 점점 더 많은 관심을 받고 있습니다. 이러한 질병은 대부분 생물학적 제제 및 기타 약물의 외인성 투여를 필요로 합니다. 이러한 주사기를 발전시킴으로써 장기간에 걸쳐 표적화되고 신뢰할 수 있는 자가 투여를 가능하게 할 수 있는 기회가 있습니다. 편안함과 사용 편의성을 개선함으로써 환자의 순응도와 건강 결과를 크게 향상시킬 수 있습니다.
• 소아용 애플리케이션 : 정기적인 투약이 필요한 어린 환자들도 웨어러블 인젝터의 잠재적 후보이기 때문에 소아용 애플리케이션의 성장 잠재력은 매우 큽니다. 소아가 쉽게 사용할 수 있는 작은 크기, 복용량 조절 및 안전 조치를 제공하는 장치를 설계하는 것이 중요합니다. 타겟팅된 혁신은 소아 환자들의 치료 순응도를 높이고, 이 계층의 만성질환에 대한 시장 매력을 높일 수 있습니다.
• 신흥 시장 : 아시아, 아프리카, 라틴아메리카 등 신흥 경제 국가에서는 웨어러블 인젝터의 보급이 확대될 가능성이 있습니다. 이들 지역에서는 만성질환에 대한 기회가 증가하고 있으며, 헬스케어에 대한 투자 확대와 함께 수요가 증가하고 있습니다. 현지의 특정 니즈에 맞춰 저렴하고 견고하며 문화적으로 민감한 기기를 설계하는 데 초점을 맞출 것입니다. 전략적 제휴와 현지 생산을 통해 시장 침투와 접근성을 높일 수 있습니다.

이러한 성장 요인은 웨어러블 인젝터의 다양한 용도와 보급이 확대되고 있음을 보여줍니다. 당뇨병 치료, 종양 치료, 자가면역질환 치료, 소아용 제제, 미개척 지역 등 다양한 분야에서 이 분야가 확대되고 있습니다. 이는 환자의 전반적인 치료 결과를 개선할 뿐만 아니라 시장 성장과 혁신의 기회를 창출할 수 있습니다.

웨어러블 인젝터 시장의 촉진요인 및 과제

웨어러블 인젝터 시장에는 성장을 촉진하는 요인과 성장을 저해하는 요인과 과제가 많이 존재합니다. 산업을 결정하는 주요 요인으로는 기술, 경제 상황, 정책적 요인 등이 있습니다.

웨어러블 인젝터 시장을 주도하는 요인은 다음과 같습니다.

• 기술 발전 : 기술 발전은 여전히 웨어러블 인젝터 시장의 기본 동인입니다. 약물전달 시스템의 개선, 장치의 소형화, 디지털 건강 시스템과의 통합과 같은 새로운 기술은 웨어러블 인젝터의 성능과 매력을 향상시키고 있습니다. 이러한 혁신은 환자들에게 보다 정확하고 효과적인 약물전달을 가능하게 하여 시장의 성장과 보급을 촉진하고 있습니다.
• 만성질환의 증가 : 당뇨병, 암, 자가면역질환 등 만성질환이 증가하면서 웨어러블 인젝터에 대한 수요가 증가하고 있습니다. 이러한 장비는 장기적인 치료가 필요한 환자를 돕기 위해 설계되었습니다. 만성질환 환자 수가 증가함에 따라 웨어러블 인젝터에 대한 수요는 확대될 것으로 예상됩니다.
• 자기 관리에 대한 관심 증가 : 많은 환자들이 어느 정도 독립적인 건강 관리 옵션에 대한 관심이 높아지고 있습니다. 웨어러블 인젝터는 이러한 선호도를 충족시키는 제품으로, 환자는 복잡한 절차 없이도 주사기를 사용할 수 있습니다. 환자 중심의 치료에 대한 관심이 높아짐에 따라 웨어러블 인젝터의 인기는 더욱 높아질 것으로 보입니다.

웨어러블 인젝터 시장의 과제는 다음과 같습니다.

• 개발 및 생산 비용 : 개발 및 생산 비용 : 웨어러블 인젝터 개발 및 생산에는 다양한 기술 통합 및 규제 요건 충족 등 높은 비용이 소요됩니다. 이러한 비용은 중소기업의 시장 진입을 제한하고 장비의 가격 경쟁력에 영향을 미칠 수 있습니다.
• 규제 문제 및 규정 준수 : 웨어러블 인젝터 기업들은 발전에도 불구하고 규제 장벽에 직면해 있습니다. 안전성과 유효성 기준을 충족하는 제품을 개발하는 데는 수년이 걸리고 많은 투자가 필요합니다. 이러한 규제 문제는 신제품 출시를 복잡하게 만들고 출시 일정을 지연시킬 수 있습니다.
• 환자 수용 및 순응도 : 웨어러블 인젝터 기술의 수용성과 순응도는 도전 과제입니다. 편안함, 사용 편의성, 이점 인식과 같은 요소는 새로운 기술에 대한 환자의 태도에 큰 영향을 미칩니다. 이러한 문제를 해결하지 못하면 환자 순응도와 시장 침투가 제한될 수 있습니다.

웨어러블 인젝터 시장 환경은 다양한 촉진요인과 도전 과제의 상호 작용에 의해 형성되고 있습니다. 기술 발전, 만성질환의 증가, 환자 중심의 치료 접근 방식은 시장 성장을 촉진합니다. 그러나 높은 개발 비용, 규제의 어려움, 환자 수용성 문제가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 웨어러블 인젝터 분야의 발전과 성공을 위해서는 이러한 요인들을 해결하는 것이 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 웨어러블 인젝터 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 웨어러블 인젝터 시장 동향(2018-2023년)과 예측(2024-2030년)
• 웨어러블 인젝터 세계 시장, 유형별
  • 체내 주사기
  • 오프 바디 인젝터
• 웨어러블 인젝터 세계 시장, 기술별
  • 스프링 기반
  • 모터 기반
  • 로터리 펌프
  • 확장 배터리
  • 기타
• 웨어러블 인젝터 세계 시장, 치료별
  • 면역종양학
  • 당뇨병
  • 심혈관질환
  • 기타
• 웨어러블 인젝터 세계 시장, 최종 용도별
  • 병원과 진료소
  • 재택 헬스케어 환경

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 웨어러블 인젝터 세계 시장
• 북미의 웨어러블 인젝터 시장
• 유럽의 웨어러블 인젝터 시장
• 아시아태평양의 웨어러블 인젝터 시장
• 기타 지역의 웨어러블 인젝터 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 웨어러블 인젝터 시장의 유형별 성장 기회
  • 세계의 웨어러블 인젝터 시장의 기술별 성장 기회
  • 세계의 웨어러블 인젝터 시장의 치료별 성장 기회
  • 세계의 웨어러블 인젝터 시장의 최종 용도별 성장 기회
  • 지역별 세계의 웨어러블 인젝터 시장 성장 기회
• 세계의 웨어러블 인젝터 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 웨어러블 인젝터 시장 생산능력 확대
  • 세계의 웨어러블 인젝터 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

영문목차

Wearable Injector Trends and Forecast

The future of the global wearable injector market looks promising with opportunities in the hospital & clinic and home healthcare setting markets. The global wearable injector market is expected to reach an estimated $14.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are the growing focus on patient convenience and the rising demand for home-based treatment.

• Lucintel forecasts that, within the type category, on-body injectors are expected to witness higher growth over the forecast period due to their growing popularity as these patches are easy to use at home, water resistant, and comfortable to wear on the skin (stomach).
• Within the end-use category, home healthcare setting is expected to witness higher growth over the forecast period due to growing demand for self-administration of medication and the desire to reduce healthcare expenses.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to growing cases of chronic & lifestyle-related diseases, the availability of robust healthcare infrastructure, and the presence of key players in the region.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Wearable Injector Market

The developments in wearable injectors have been supplemented by an evolution of the world and its forces, as well as the likely implications for the future. Such developments are altering the features of the devices, the experiences of the patients, and the actual health services rendered.

• Integration with Digital Health Platforms: Wearable injectors have begun to integrate with various digital health innovations that offer remote monitoring and transmission of data. As a result, chronic diseases are better controlled since insights from data analytics and personalized treatment plans are used. There is also improved engagement with patients, as they receive information about their medications and health, leading to better adherence and improved outcomes.
• Enhanced User Comfort and Convenience: The latest trend focuses on making patients wearing wearable injectors more comfortable and devices easier to use. Smaller, lighter devices and those with improved ergonomic designs are making usage less painful. Moreover, enhancements in delivery methods and adhesives contribute to a more pleasant user experience; these changes are key in fostering adherence to wearables and enhancing patient experience.
• Smart Technology and Connectivity: These devices now include smart technology in the form of Bluetooth and Wi-Fi, enabling better mobile app and health system integration. Users can manage their medication, set alarms, alert their healthcare providers, and monitor their medication even when outside the clinic. This enhances chronic disease management by facilitating effective communication and personalization.
• Personalized Medicine and Customization: In alignment with the trend toward personalized medicine, the design of wearable injectors has also evolved. There is a move toward devices tailored to individual patients in terms of drug delivery rates and dosages. Such personalization increases treatment effectiveness while reducing side effects, as therapies can be customized to meet the specific needs of each patient.
• Increased Focus on Meeting Regulatory Requirements: As concerns about patient safety and efficacy heighten, there is more emphasis on complying with regulatory needs. Manufacturers are investing in R&D to ensure that all necessary regulations, including those required by the FDA and European authorities, are met. This focus not only results in high-quality products but also enhances the confidence of clients and health professionals.

The aforementioned trends are enhancing functionality, improving user experience, and promoting innovation in the development of the wearable injector market, collectively shaping its direction. The increasing development of new health platforms and smart technologies is promoting the ease of use and effectiveness of these devices, while personalization and regulatory requirements ensure standards. As these trends continue to emerge, the use of wearable injectors in chronic disease management is evolving, reflecting potential future directions for the market.

Recent Developments in the Wearable Injector Market

The wearable injector market is evolving rapidly due to innovations in technology, changes in policies, and the shifting demands of patients. These trends are shaping the drug delivery systems of the future and enhancing healthcare delivery.

• Compression in Drug Delivery Steroids: Recently, advancements have been made in drug delivery technology to boost the efficacy and performance characteristics of wearable injectors. The variety of micro-needle arrays and pump systems launched for injection have provided greater precision and addressed adverse effects caused by conventional injectors. These developments enhance treatment adherence and facilitate long-term care.
• Fit with Mobile Health Applications: There is growing compliance and use of wearable injectors with mobile health applications, allowing users to administer medications, report health data, and interact more clearly with medical practitioners. Such functionality improves disease management by providing timely information and advice. It also enhances remote patient management by facilitating timely data collection and interventions.
• Mechanisms for Compact and Forward-Looking Devices: The trend toward miniaturization is making wearable injectors more compact and portable. As miniaturization technologies improve, devices become smaller, less obtrusive, and more user-friendly. This trend benefits patients undergoing constant medical treatment who require less conspicuous and convenient delivery methods.
• Improvements in Battery Life and Power Management: Advances in battery technologies are extending the useful life of wearable injectors, reducing the frequency of charging or battery replacements. Increased efficiency in energy use enhances the performance and reliability of these devices. A long battery life is essential for patient convenience and maintaining specified drug delivery standards.
• Broader Range of Conditions: Designers of wearable injectors are now targeting a wider range of medical conditions beyond diabetes, including rheumatoid arthritis and multiple sclerosis. The demand for chronic disease management and the functionality of wearable injectors explain this growth. Developing devices that address needs in other therapeutic fields creates new market opportunities and fulfills unmet needs.

Strategic Growth Opportunities for Wearable Injector Market

The expansion of the wearable injector market is tied to the rise of new technologies and the increase in chronic diseases. Wearable injectors are creating lucrative strategic market opportunities. These improvements aim not only to enhance patient experience but also to generate opportunities for the healthcare industry, whether for companies or innovators.

• Diabetes Management: Thousands of developments in the production of wearable injectors focus on managing diabetes, as the condition has reached pandemic levels. These devices allow for better insulin administration, continuous blood glucose monitoring, and interaction with blood glucose meters. Such innovations positively impact patient adherence and glycemic control. Additionally, developing patient-centric designs and facilitating communication with medical personnel can enhance quality of life and incorporate new functionalities into the devices.
• Oncology Treatments: There is a surge of interest in using wearable injectors for delivering chemotherapeutics or targeted therapies in oncology. These devices enable controlled and continuous drug flow, potentially enhancing pharmacological efficacy while minimizing adverse effects compared to conventional administration methods. The opportunity lies in developing wearable injectors with advanced drug delivery systems and therapy monitoring capabilities for individual cancer patients.
• Autoimmune Diseases: The fight against autoimmune diseases such as rheumatoid arthritis and multiple sclerosis increasingly focuses on wearable injectors. Many of these diseases require exogenous administration of biologics and other medications. There are opportunities to advance these injectors, allowing for targeted and reliable self-administration over time. Improving comfort and usability can significantly enhance patient adherence and health outcomes.
• Pediatric Applications: The potential for growth in pediatric applications is significant, as even young patients requiring regular medication are potential candidates for wearable injectors. It is important to design devices that are smaller, child-friendly, and feature adjustable dosage and safety measures. Targeted innovation can support treatment adherence among children and increase market appeal for chronic diseases in this demographic.
• Emerging Markets: There is potential for penetrating wearable injectors in developing economies, such as those in Asia, Africa, and Latin America. These regions are increasingly facing chronic diseases, coupled with growing investments in healthcare, fueling demand. The focus could be on designing affordable, robust, and culturally sensitive devices tailored to specific local needs. Strategic alliances and local production can also enhance market penetration and accessibility.

These growth factors testify to the multitude of uses and expanding reach of wearable injectors. In the fields of diabetes care, oncology, autoimmune disease treatment, pediatric formulations, and untapped regions, the sector is poised for expansion. This not only improves overall patient outcomes but also creates opportunities for market growth and innovation.

Wearable Injector Market Driver and Challenges

The wearable injector market is characterized by numerous drivers and challenges that either support growth or hinder it. Key forces determining the industry include technology, economic conditions, and policy factors.

The factors driving the wearable injector market include:

• Technological Advancements: Advances in technology remain a fundamental driver in the wearable injector market. Emerging technologies, such as improved drug delivery systems, device miniaturization, and integration with digital health systems, enhance the performance and attractiveness of wearable injectors. Such developments enable more accurate and effective drug delivery to patients, fueling market growth and adoption.
• Rising Occurrence of Chronic Diseases: Chronic conditions, such as diabetes, cancer, and autoimmune diseases, are increasing, boosting the need for wearable injectors. These devices are designed to assist patients who require long-term therapy. As the number of patients with chronic conditions rises, the demand for wearable injectors is anticipated to grow.
• Rising Interest in Self-Management: Many patients are increasingly interested in health management options that allow for some level of independence. Wearable injectors satisfy this preference, enabling patients to use them without complicated procedures. As the emphasis on patient-centered care continues to grow, so will the popularity of wearable injectors.

Challenges in the wearable injector market include:

• Cost of Development and Production: High costs associated with the development and production of wearable injectors-including integrating various technologies and meeting regulatory requirements-can be prohibitive. These costs may limit market entry for smaller companies and affect the affordability of devices.
• Regulatory Issues and Compliance: Despite progress, wearable injector companies face regulatory hurdles. Developing products that meet safety and efficacy standards can take years and require significant investment. These regulatory challenges can complicate new product introductions and delay launch timelines.
• Patient Acceptance and Adherence: Acceptance and adherence to wearable injector technology pose challenges. Factors such as comfort, ease of use, and perceived benefits significantly influence patients' attitudes toward new technologies. Failure to address these concerns limits patient compliance and market penetration.

The landscape for the wearable injector market is shaped by the interaction between various drivers and challenges. Technological advancements, increasing incidences of chronic diseases, and the patient-centered care approach enhance market growth. However, high development costs, regulatory difficulties, and patient acceptance issues hinder progress. Addressing these factors is crucial for the development and success of the wearable injector sector.

List of Wearable Injector Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies wearable injector companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the wearable injector companies profiled in this report include-

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

Wearable Injector by Segment

The study includes a forecast for the global wearable injector by type, technology, therapy, end use, and region.

Wearable Injector Market by Type [Analysis by Value from 2018 to 2030]:

• On-Body Injector
• Off-Body Injector

Wearable Injector Market by Technology [Analysis by Value from 2018 to 2030]:

• Spring Based
• Motor Based
• Rotary Pump
• Expanding Battery
• Others

Wearable Injector Market by Therapy [Analysis by Value from 2018 to 2030]:

• Immuno-Oncology
• Diabetes
• Cardiovascular Disease
• Others

Wearable Injector Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Home Healthcare Setting

Wearable Injector Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Wearable Injector Market

Advances in medical technology and the demand for more patient-oriented technologies have significantly contributed to the popularity of wearable injectors-devices designed for prolonged use just under the skin. These devices assist in managing chronic diseases, especially diabetes and several autoimmune conditions, by offering a simple and painless mode of drug delivery. The growth trajectory for wearable injectors is promising, with major developments occurring in key developing countries.

• United States: In the U.S., considerable progress has been made in wearable injectors, with new designs focusing on user comfort and enhancing the socio-technical features of the devices. Next-generation devices made by Insulet and Dexcom have been recently deployed, claiming to provide more utilitarian, neat, and functional features. There has also been a significant shift toward integrating digital health technologies, such as smartphone connectivity, enabling continuous patient tracking across various platforms. The delivery of FDA approvals for advanced wearable injectors has further enhanced their acceptance among patients with chronic illnesses.
• Germany: Germany maintains a strong focus on wearable injectors, emphasizing accuracy and comfort. German companies are conceptualizing better interfaces and drug delivery systems while actively seeking innovations in monitoring technology. It is expected that injectable solutions will be linked to systems that monitor patients continuously. The German medical device industry is committed to developing high-quality products that meet prescribed standards.
• India: The wearable injector industry in India is expanding, focusing on accessibility and affordability. Organizations are developing cost-effective, user-friendly devices in response to the high prevalence of diabetes. There has been a rise in partnerships between Indian tech start-ups and foreign companies, enhancing innovation and local manufacturing capabilities. Programs aimed at broadening the scope of health technology reforms are also contributing to advancements in wearable injectors in the country.
• Japan: Japan has made strides in wearable injectors, emphasizing advanced technology development in response to its aging population. Manufacturers are focusing on developing small, high-performance devices that fit compactly and efficiently deliver drugs. Efforts are underway to create devices that are easy to use and highly accurate. The regulatory landscape in Japan facilitates the introduction of novel wearable injectors, while the country's strong emphasis on healthcare technology improvement is driving market growth.

Features of the Global Wearable Injector Market

Market Size Estimates: Wearable injector market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Wearable injector market size by various segments, such as by type, technology, therapy, end use, and region in terms of value ($B).

Regional Analysis: Wearable injector market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, therapies, end uses, and regions for the wearable injector market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the wearable injector market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the wearable injector market by type (on-body injector and off-body injector), technology (spring based, motor based, rotary pump, expanding battery, and others), therapy (immuno-oncology, diabetes, cardiovascular disease, and others), end use (hospitals and clinics and home healthcare setting), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Wearable Injector Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Wearable Injector Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Wearable Injector Market by Type
  • 3.3.1: On-Body Injector
  • 3.3.2: Off-Body Injector
• 3.4: Global Wearable Injector Market by Technology
  • 3.4.1: Spring Based
  • 3.4.2: Motor Based
  • 3.4.3: Rotary Pump
  • 3.4.4: Expanding Battery
  • 3.4.5: Others
• 3.5: Global Wearable Injector Market by Therapy
  • 3.5.1: Immuno-Oncology
  • 3.5.2: Diabetes
  • 3.5.3: Cardiovascular Disease
  • 3.5.4: Others
• 3.6: Global Wearable Injector Market by End Use
  • 3.6.1: Hospitals and Clinics
  • 3.6.2: Home Healthcare Setting

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Wearable Injector Market by Region
• 4.2: North American Wearable Injector Market
  • 4.2.1: North American Market by Type: On-Body Injector and Off-Body Injector
  • 4.2.2: North American Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.3: European Wearable Injector Market
  • 4.3.1: European Market by Type: On-Body Injector and Off-Body Injector
  • 4.3.2: European Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.4: APAC Wearable Injector Market
  • 4.4.1: APAC Market by Type: On-Body Injector and Off-Body Injector
  • 4.4.2: APAC Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.5: ROW Wearable Injector Market
  • 4.5.1: ROW Market by Type: On-Body Injector and Off-Body Injector
  • 4.5.2: ROW Market by End Use: Hospitals and Clinics and Home Healthcare Setting

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Wearable Injector Market by Type
  • 6.1.2: Growth Opportunities for the Global Wearable Injector Market by Technology
  • 6.1.3: Growth Opportunities for the Global Wearable Injector Market by Therapy
  • 6.1.4: Growth Opportunities for the Global Wearable Injector Market by End Use
  • 6.1.5: Growth Opportunities for the Global Wearable Injector Market by Region
• 6.2: Emerging Trends in the Global Wearable Injector Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Wearable Injector Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Wearable Injector Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ypsomed
• 7.2: Amgen
• 7.3: Subcuject
• 7.4: Enable Injections
• 7.5: Medtronic